Current Assets
Cash & Equivalents
CVS Health Cash & Equivalents increased by 12.1% to $9.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.6%, from $10.35B to $9.77B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows a downward trend with a -4.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ4 2012
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase suggests improved liquidity and potential for investment, while a decrease may indicate heavy capital expenditure or cash burn.
Detailed definition
This represents the most liquid assets held by the company, including physical currency, bank deposits, and short-term i...
Peer comparison
Standard across all industries; peers typically maintain cash levels proportional to their working capital needs.
Metric ID:
cash_and_equivalentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.3B | $13.04B | $12.69B | $11.61B | $12.46B | $17.56B | $13.31B | $14.96B | $14.13B | $13.38B | $8.53B | $10.11B | $12.82B | $7.14B | $8.88B | $10.35B | $12.03B | $9.35B | $8.71B | $9.77B |
| QoQ Change | — | +26.7% | -2.7% | -8.5% | +7.3% | +40.9% | -24.2% | +12.4% | -5.5% | -5.3% | -36.3% | +18.6% | +26.8% | -44.3% | +24.4% | +16.5% | +16.2% | -22.2% | -6.8% | +12.1% |
| YoY Change | — | — | — | — | +21.0% | +34.7% | +4.8% | +28.8% | +13.4% | -23.8% | -35.9% | -32.4% | -9.3% | -46.6% | +4.2% | +2.4% | -6.2% | +31.0% | -1.9% | -5.6% |
Range$7.14B – $17.56B
CAGR-1.1%
Avg YoY Growth-1.3%
Median YoY Growth+0.2%
Cash & Equivalents at Other Companies
Frequently Asked Questions
- What is CVS Health's cash & equivalents?
- CVS Health (CVS) reported cash & equivalents of $9.77B in Q1 2026.
- How has CVS Health's cash & equivalents changed year-over-year?
- CVS Health's cash & equivalents decreased by 5.6% year-over-year, from $10.35B to $9.77B.
- What is the long-term trend for CVS Health's cash & equivalents?
- Over 5 years (2020 to 2025), CVS Health's cash & equivalents has grown at a -4.6% compound annual growth rate (CAGR), from $11.04B to $8.71B.
- What does cash & equivalents mean?
- The total amount of cash and highly liquid investments the company has on hand.